108 related articles for article (PubMed ID: 1851518)
21. Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
Li X; Lv Y; Yuan A; Yi S; Ma Y; Li Z
Oncol Rep; 2010 Aug; 24(2):441-8. PubMed ID: 20596631
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
23. [Studies on production of human epidermal growth factor and its receptor in human hepatoma cell line (PLC/PRF/5)].
Hase K
Nihon Shokakibyo Gakkai Zasshi; 1987 Jan; 84(1):128. PubMed ID: 3033358
[No Abstract] [Full Text] [Related]
24. Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18-21 mutations.
Nikolova D; Trajkovska M; Trpcevska EN; Eftimov A; Jovanovik R; Janevska V
Rom J Intern Med; 2022 Sep; 60(3):153-159. PubMed ID: 35476635
[No Abstract] [Full Text] [Related]
25. [Expression of c-erbB-2 protein and EGF receptor in hepatitis B, cirrhosis and hepatocellular carcinoma].
Su Q; Liu Y
Zhonghua Bing Li Xue Za Zhi; 1995 Apr; 24(2):93-5. PubMed ID: 7788735
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
Buckley AF; Burgart LJ; Kakar S
Hum Pathol; 2006 Apr; 37(4):410-4. PubMed ID: 16564914
[TBL] [Abstract][Full Text] [Related]
27. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma.
Liu D; Aguirre Ghiso J; Estrada Y; Ossowski L
Cancer Cell; 2002 Jun; 1(5):445-57. PubMed ID: 12124174
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of Tumor Tissue Biopsy for Predicting the Biological Behavior of Hepatocellular Carcinoma.
Shioga T; Kondo R; Ogasawara S; Akiba J; Mizuochi S; Kusano H; Mihara Y; Tanigawa M; Kinjyo Y; Naito Y; Kuromatsu R; Nakashima O; Yano H
Anticancer Res; 2020 Jul; 40(7):4105-4113. PubMed ID: 32620659
[TBL] [Abstract][Full Text] [Related]
29. γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition.
Xiao H; Tong R; Ding C; Lv Z; Du C; Peng C; Cheng S; Xie H; Zhou L; Wu J; Zheng S
Oncotarget; 2015 Feb; 6(4):2180-92. PubMed ID: 25537504
[TBL] [Abstract][Full Text] [Related]
30. Expressions of epidermal growth factor family and its receptor in hepatocellular carcinoma cell lines: relationship to cell proliferation.
Hisaka T; Yano H; Haramaki M; Utsunomiya I; Kojiro M
Int J Oncol; 1999 Mar; 14(3):453-60. PubMed ID: 10024677
[TBL] [Abstract][Full Text] [Related]
31. [Expression and significance of epidermal growth factor receptor variant type III in hepatocellular carcinoma].
Ou C; Wu FX; Luo Y; Cao J; Zhao YN; Yuan WP; Li Y; Su JJ
Ai Zheng; 2005 Feb; 24(2):166-9. PubMed ID: 15694026
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma.
Miura H; Miyazaki T; Kuroda M; Oka T; Machinami R; Kodama T; Shibuya M; Makuuchi M; Yazaki Y; Ohnishi S
J Hepatol; 1997 Nov; 27(5):854-61. PubMed ID: 9382973
[TBL] [Abstract][Full Text] [Related]
33. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
Fujioka M; Nakashima Y; Nakashima O; Kojiro M
Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002
[TBL] [Abstract][Full Text] [Related]
34. GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth.
Uemura T; Kametaka S; Waguri S
Sci Rep; 2018 Jan; 8(1):1368. PubMed ID: 29358589
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor in human hepatocellular carcinoma.
Hamazaki K; Yunoki Y; Tagashira H; Mimura T; Mori M; Orita K
Cancer Detect Prev; 1997; 21(4):355-60. PubMed ID: 9232327
[TBL] [Abstract][Full Text] [Related]
36. [Comparative studies on the banding characteristics of insulin receptor in human hepatocellular carcinoma and adjacent liver tissues].
Ou X; Kuang A; Liang Z; Cheng Z
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):32-4. PubMed ID: 12599422
[TBL] [Abstract][Full Text] [Related]
37. Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma.
Inui Y; Higashiyama S; Kawata S; Tamura S; Miyagawa J; Taniguchi N; Matsuzawa Y
Gastroenterology; 1994 Dec; 107(6):1799-804. PubMed ID: 7958694
[TBL] [Abstract][Full Text] [Related]
38. GP78 Cooperates with Dual-Specificity Phosphatase 1 To Stimulate Epidermal Growth Factor Receptor-Mediated Extracellular Signal-Regulated Kinase Signaling.
Kho DH; Uddin MH; Chatterjee M; Vogt A; Raz A; Wu GS
Mol Cell Biol; 2019 Jun; 39(11):. PubMed ID: 31061093
[TBL] [Abstract][Full Text] [Related]
39. HCC Specific Protein Network Involving Interactions of EGFR with A-Raf and Transthyretin: Experimental Analysis and Computational Biology Correlates.
Ranjpour M; Katare DP; Wajid S; Jain SK
Anticancer Agents Med Chem; 2018; 18(8):1163-1176. PubMed ID: 29732980
[TBL] [Abstract][Full Text] [Related]
40. The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis.
Berasain C; Avila MA
J Gastroenterol; 2014 Jan; 49(1):9-23. PubMed ID: 24318021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
